Andesa Financial Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $919K | Buy |
5,926
+845
| +17% | +$131K | 0.47% | 56 |
|
|
2022
Q4 | $821K | Sell |
5,081
-396
| -7% | -$64K | 0.45% | 62 |
|
|
2022
Q3 | $735K | Buy |
5,477
+735
| +15% | +$98.6K | 0.26% | 76 |
|
|
2022
Q2 | $726K | Buy |
4,742
+341
| +8% | +$52.2K | 0.46% | 59 |
|
|
2022
Q1 | $716K | Sell |
4,401
-785
| -15% | -$128K | 0.39% | 62 |
|
|
2021
Q4 | $702K | Buy |
5,186
+327
| +7% | +$44.3K | 0.34% | 68 |
|
|
2021
Q3 | $522K | Buy |
4,859
+617
| +15% | +$66.3K | 0.28% | 82 |
|
|
2021
Q2 | $477K | Sell |
4,242
-438
| -9% | -$49.3K | 0.14% | 98 |
|
|
2021
Q1 | $506K | Buy |
4,680
+65
| +1% | +$7.03K | 0.16% | 91 |
|
|
2020
Q4 | $496K | Buy |
4,615
+164
| +4% | +$17.6K | 0.33% | 71 |
|
|
2020
Q3 | $390K | Buy |
4,451
+1,722
| +63% | +$151K | 0.16% | 101 |
|
|
2020
Q2 | $268K | Buy |
+2,729
| New | +$268K | 0.24% | 88 |
|
|
2019
Q3 | – | Sell |
-5,295
| Closed | -$385K | – | 103 |
|
|
2019
Q2 | $385K | Sell |
5,295
-50,485
| -91% | -$3.67M | 0.36% | 64 |
|
|
2019
Q1 | $4.49M | Buy |
55,780
+33,101
| +146% | +$2.66M | 2.21% | 17 |
|
|
2018
Q4 | $2.09M | Buy |
22,679
+13,589
| +149% | +$1.25M | 2.49% | 13 |
|
|
2018
Q3 | $857K | Sell |
9,090
-13,609
| -60% | -$1.28M | 1.32% | 31 |
|
|
2018
Q2 | $2.1M | Buy |
22,699
+220
| +1% | +$20.4K | 3.39% | 7 |
|
|
2018
Q1 | $2.13M | Sell |
22,479
-988
| -4% | -$93.4K | 3.52% | 7 |
|
|
2017
Q4 | $2.27M | Buy |
+23,467
| New | +$2.27M | 3.36% | 5 |
|